Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
mouse challenge
Description:
Experimental exposure of mice to a pathogen or biological agent, commonly used to assess vaccine potency or protection.
Related topics:
Influenza Virus Research Studies (15%),
Microbial infections and disease research (10%)
OpenAlex ID:
keywords/mouse-challenge
Listeria monocytogenes in Raw Milk: Detection, Incidence, and Pathogenicity
1987
·
J. Lovett
, D.W. Francis
, et al.
·
Journal of Food Protection
·
382
Immunization of Humans with Recombinant Pneumococcal Surface Protein A (rPspA) Elicits Antibodies That Passively Protect Mice from Fatal Infection withStreptococcus pneumoniaeBearing Heterologous PspA
2000
·
David E. Briles
, Susan K. Hollingshead
, et al.
·
The Journal of Infectious Diseases
·
298
Microarray Analysis of Pneumococcal Gene Expression during Invasive Disease
2004
·
Carlos J. Orihuela
, Jana N. Radin
, et al.
·
Infection and Immunity
·
273
New Immunotype Schema for Pseudomonas aeruginosa Based on Protective Antigens
1969
·
M. W. Fisher
, H. B. Devlin
, et al.
·
Journal of Bacteriology
·
258
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein
1993
·
R M Kinney
, G J Chang
, et al.
·
Journal of Virology
·
224
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
2021
·
Sebastian Weigang
, Jonas Fuchs
, et al.
·
Nature Communications
·
191
PDF
A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease
2024
·
Adam Zuiani
, Charles L. Dulberger
, et al.
·
Cell
·
172
Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses
2005
·
S.M. Brookes
, G. Parsons
, et al.
·
Vaccine
·
134
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
2020
·
Weina Sun
, Sarah R. Leist
, et al.
·
EBioMedicine
·
120
PDF
Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2
2009
·
Anding Zhang
, Bo Chen
, et al.
·
Vaccine
·
119
Virulence factors ofFrancisella tularensis
1977
·
A. M. Hood
·
Journal of Hygiene
·
114
PDF
Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus
2013
·
Gale E. Smith
, David C. Flyer
, et al.
·
Vaccine
·
110
PDF
Coxiella burnetii DNA, But Not Viable Bacteria, in Dairy Products in France
2013
·
Carole Eldin
, Emmanouil Angelakis
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
103
Isolation of virulent Yersinia enterocolitica from porcine tongues
1981
·
M P Doyle
, M B Hugdahl
, et al.
·
Applied and Environmental Microbiology
·
97
PDF
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
2021
·
Alina Tscherne
, Jan Hendrik Schwarz
, et al.
·
Proceedings of the National Academy of Sciences
·
94
Characterization of DegU, a response regulator inListeria monocytogenes, involved in regulation of motility and contributes to virulence
2004
·
Gitte M. Knudsen
, John E. Olsen
, et al.
·
FEMS Microbiology Letters
·
92
Epitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized Antibody
2007
·
Ching-Juh Lai
, Ana P. Goncalvez
, et al.
·
Journal of Virology
·
91
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
2017
·
Neal Van Hoeven
, Christopher B. Fox
, et al.
·
Scientific Reports
·
90
PDF
Antibody Breadth and Protective Efficacy Are Increased by Vaccination with Computationally Optimized Hemagglutinin but Not with Polyvalent Hemagglutinin-Based H5N1 Virus-Like Particle Vaccines
2011
·
Brendan M. Giles
, Stephanie J. Bissel
, et al.
·
Clinical and Vaccine Immunology
·
84
PDF
Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
2017
·
Henning Jacobsen
, Madhusudan Rajendran
, et al.
·
mBio
·
83
Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs
2009
·
Nina Lagerqvist
, Jonas Näslund
, et al.
·
Virology Journal
·
83
PDF
The AcrAB RND efflux system from the live vaccine strain ofFrancisella tularensisis a multiple drug efflux system that is required for virulence in mice
2008
·
Xiaowen R. Bina
, Christy L. Lavine
, et al.
·
FEMS Microbiology Letters
·
82
Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets
2015
·
S. Pillet
, T. Racine.
, et al.
·
Vaccine
·
76
Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and Ebola
2013
·
Devon J Shedlock
, Jenna Aviles
, et al.
·
Molecular Therapy
·
76
Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine
2009
·
Julia Romanova
, Brigitte M. Krenn
, et al.
·
PLoS ONE
·
74
PDF
Show more works
View as search
Works count:
335
Citation count:
7,319
Year
Topic
Type